Bionano retires $20 million convertible debt, eliminates secured obligations

Go back to Bionano retires $20 million convertible debt, eliminates secured obligations

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

May 28, 2026 8:00 AM EDT

SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has fully retired and cancelled all outstanding Senior Secured Convertible Debentures (the "Debentures"). The Company used cash on hand to retire the Debentures, which were originally issued in May 2024 in the aggregate face value of $20,000,000.

The retirement of the Debentures completes the debt restructuring the Company undertook in May 2024 and results in Bionano carrying no outstanding secured debt obligations. With the retirement, all liens on the Company's assets are released and the associated restrictive covenants are extinguished, providing the... More